$ 0.00 USD
This product is out of stock.
Product is not available in this quantity.
PT-141 Peptide is a doctor-reviewed peptide therapy studied for its potential to support confidence, vitality, and intimate wellness in both men and women. Unlike traditional treatments that focus on blood flow or hormones, PT-141 Peptide works within the brain’s natural pathways linked to desire and mood. This non-hormonal option offers a discreet, evidence-based approach for those seeking renewed balance and connection.
Common PT-141 Peptide uses include supporting natural libido, improving mood, and helping restore emotional intimacy in a safe, guided way. Many clients choose this peptide therapy to feel more in tune with their body and enhance well-being without hormone replacement.
⸻
This product is intended for general wellness and is not designed to diagnose, treat, cure or prevent any disease. Images are for illustrative purposes only. Above Wellness does not manufacture or compound medications.
PT-141 Peptide (also known as Bremelanotide) stimulates melanocortin-4 receptors (MC4R) in the hypothalamus, the part of the brain that controls mood and motivation. By activating these receptors, PT-141 may enhance natural signals related to desire and emotional connection. Unlike other treatments that target circulation, PT-141 acts on neurological pathways, making it a non-hormonal option for intimate wellness.
Note: Always follow personalised dosing instructions after consultation with your provider.
Clinical evidence supports PT-141 as a scientifically studied, brain-based approach to wellness. While individual results vary, these studies help explain why PT-141 has become a trusted option for those seeking a safe, guided way to support confidence and intimacy.
In two phase 3 clinical trials involving more than 1,200 premenopausal women, PT-141 (bremelanotide) was shown to significantly improve sexual desire and reduce distress related to low desire compared with placebo (Kingsberg et al., 2019, Obstetrics & Gynecology).
Over 24 weeks, desire scores increased by an average of +0.35 points compared to placebo. The most common side effects were mild and transient, including nausea, flushing, and headache (≥10%).
Separate long-term studies suggest that continued use under medical supervision may sustain or further enhance improvements in sexual desire over time.
PT-141 activates melanocortin-4 receptors (MC4R) in the brain’s hypothalamus, regions involved in emotion and sexual desire.
In a neuroimaging study (Thurston et al., 2022, The Journal of Clinical Investigation), MC4R activation increased sexual desire for up to 24 hours and enhanced activity in brain areas such as the cerebellum and supplementary motor area while strengthening connectivity between the amygdala and insula.
In simple terms, PT-141 helps stimulate the brain’s natural desire pathways—supporting mood, connection, and vitality through neurological activity rather than hormonal change.
Note: Always use PT-141 under licensed provider supervision. Research continues to explore its full potential and long-term applications.
Injection Form: The most clinically researched and precise dosing method, ensuring consistent absorption. This method allows your provider to personalise your PT-141 peptide dose based on your goals and tolerance.
Nasal Spray: Explored in early studies but limited by variable absorption results. Some people prefer the nasal spray for convenience and needle-free use, especially for on-the-go dosing. However, absorption can vary between users, so healthcare supervision is essential when considering this delivery route.
Troche Form: Convenient but less researched, as peptide structures may degrade during digestion. Troches (dissolvable tablets) are easy to use and may appeal to those who prefer oral administration. Because the digestive process can reduce the peptide’s bioavailability, providers often recommend troches as a secondary option rather than a first-line choice.
The concentration of clinical research on injection delivery reflects both regulatory requirements and the scientific need for consistent, measurable dosing in controlled studies.
At Above Wellness, your safety, confidence, and privacy always come first. We’re a LegitScript-certified telehealth provider that connects you with licensed U.S. clinicians who specialise in evidence-based peptide therapies, including PT-141 Peptide.
Above Wellness is dedicated to providing science-driven wellness solutions that empower you to feel your best — safely, confidently, and under trusted professional care.
Getting started with Above Wellness is easy, secure, and fully licensed.
Rediscover confidence and connection through safe, evidence-based wellness care. Begin your PT-141 Peptide consultation today for professional guidance and trusted support every step of the way.
A: PT-141 (Bremelanotide) is a peptide that boosts sexual desire by acting on the brain, not just blood flow. It works for both men and women.
A: Inject subcutaneously (under the skin) in the abdomen or thigh, about 45 minutes to 2 hours before intimacy.
A: Most use it 1 to 3 times per week. Your provider will guide dosing based on your needs and results.
A: Yes. PT-141 is FDA-approved for low libido in women and commonly used off-label in both pre- and post-menopausal women.
A: Some people may experience nausea, flushing, or slight injection site redness, but these are usually mild and temporary.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.